News
News
-
New tool reveals how T cell responses evolve across organs
By tracking recently activated T cells over time and across tissues, researchers uncover immune dynamics that may inform future therapies for infection, cancer, and autoimmunity
-
Forbes: Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
-
TIME: 100 Health 2026
In today's changing health landscape, these leaders are advancing care, shaping policy, and driving innovations that transform lives.
-
Andrea Califano: 6 strategies for using AI to reprogram the immune system
The convergence of machine learning, synthetic biology, and immunology is changing what's possible for human health.
-
Axios: Zuckerberg and Chan bet AI can cure all disease
-
Associated Press: Zuckerberg, Chan shift bulk of philanthropy to science, focusing on AI and biology to curb disease
-
Latent Space: Priscilla Chan and Mark Zuckerberg — Frontier AI + virtual biology to solve all diseases
-
a16z Podcast: Mark Zuckerberg & Priscilla Chan — How AI will cure all disease
-
Biohub launches first large-scale scientific initiative combining frontier AI with frontier biology to cure or prevent disease
Biohub to unite data, compute, experimental science, and AI to transform and accelerate scientific research.
-
An update from our founders
We're going all in on AI-powered biology for our next chapter.
-
Launching the first large-scale scientific initiative combining frontier AI with frontier biology to solve disease
To power this initiative, we are uniting our scientific teams as a single organization: Biohub.
-
Advancing patient-led science through collaboration
The Rare As One Cycle 2 Impact Report highlights how patient communities are accelerating research and reshaping the rare disease landscape.